Trumenba

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

VaccineGonorrhea

36 competitors in Vaccine

#DrugCompanyPhaseTrials

1

Rotarix ™

GSK

Phase 3

52

Havrix

GSK

Phase 3

13

Vaxelis Vaccine

Sanofi

Phase 3

34

Varivax

GSK

Phase 3

35

Rotateq

Merck & Co.

Phase 3

36

M-M-R II Vaccine

Sanofi

Phase 3

27

Priorix

GSK

Phase 3

18

Bayer Aspirin

Bayer

Phase 1

19

Varivax Vaccine

Sanofi

Phase 3

210

Trumenba

Pfizer

Phase 3

1Show 15 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Immunogenicity2 trials

Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.

Recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT04166656·84 enrolled

Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)

Completed·UUCSF Benioff Children's Hospital Oakland·Phase 4·NCT02569632·18 enrolled

ART1 trial

MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

Completed·Pfizer·Phase 3·NCT04440163·2,431 enrolled

Immunocompromised1 trial

Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age

Completed·Pfizer·Phase 4·NCT04893811·53 enrolled

Vaccine1 trial

MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults

Recruiting·EEmory University·Phase 4·NCT07197762·125 enrolled

Gonorrhea1 trial

A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

Completed·Pfizer··NCT05873751·1,307,378 enrolled

Details

Drug Info

Related News